Plasma Cell Myeloma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-07-03
Clinical Trial Update: Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy [Phase 2]
A Phase 2 trial evaluating pembrolizumab as salvage therapy for plasma cell myeloma patients progressing after CAR-T therapy has been withdr…